TGFB1 and breast carcinoma: The authors observed that altered TGFB1 signaling levels altered breast cancer risk (intermediate vs. high signalers OR 1.27, 95% CI 0.93 – 1.74; low vs. high signalers OR 1.69, 95% CI 1.08 – 2.66).